TRVI compared with ORIC: revenue, margins and what each company keeps, and the suppliers and customers both name

TRVITrevi Therapeutics, Inc.

Mkt capRevenueRevenue

ORICOric Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

TRVITrevi Therapeutics, Inc.

ORICOric Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TRVI

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.8%▲+0.05%×0.01

May 6 '26±8.2%▼−2.73%×0.33

Apr 17 '26±17.5%▲+4.75%×0.27

Q1 FY26±11.9%▼−4.47%×0.38

ORIC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±44.4%▲+27.08%×0.61

Q1 FY26±47.2%▼−0.62%×0.01

= impliedTRVI realized, solidORIC realized, hatchedOne scale, both sides: full bar = 48%× = |realized| ÷ impliedspan: TRVI 142d · ORIC 263dSource: market data

Feb 24 '26

±40.3%

▲+14.60%

×0.36

Nov 14 '25±31.1%▲+0.49%×0.02

TRVITrevi Therapeutics, Inc.

13.54▼−1.96%· post 13.54

Mkt cap$1.9B

ORICOric Pharmaceuticals, Inc.

9.25▲+2.87%· post 9.38

ClosedOct 30 '26

Mkt cap$957.8M

Compare

ClosedOct 30 '26

TRVITrevi Therapeutics, Inc.

ORICOric Pharmaceuticals, Inc.

13.54▼−1.96%post 13.54

Price

9.25▲+2.87%post 9.38

$1.9B

Mkt cap

$957.8M

TRVI13.54▼−1.96%vsORIC9.25▲+2.87%ClosedOct 30 '26